Bobak R. Azamian, President/CEO and Board Chair at Tarsus Pharmaceuticals, Inc. (TARS), sold 20,238 shares at $15.13 ($306K) on 2023-04-28, disclosed to the SEC on 2023-05-02.
Scheduled sale ($306k) by President/CEO and Board Chair under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.13 | 4,278 | $65K | 21.2% |
| 2 | $15.13 | 4,278 | $65K | 21.2% |
| 3 | $15.10 | 5,841 | $88K | 28.8% |
| 4 | $15.10 | 5,841 | $88K | 28.8% |
| Total | $15.11 avg | 20,238 | $306K | 100% |
| Filing → |
| TARS | SELL | 2026-06-22 | $615K | — | Filing → |
| TARS | SELL | 2026-03-19 | $2.4M | — | Filing → |
| TARS | SELL | 2025-12-30 | $944K | — | Filing → |